Take Action!

Show your support for Cancer Chemotherapy Equality in Connecticut!

Right now, Senate Bill 50 – a bill that would fix the insurance coverage difference between oral cancer treatment drugs and intravenous chemotherapy – has been voted out of a Connecticut Senate committee and is awaiting a vote by the full Senate.

Fill out the form below and tell your Senator that you support this vital legislation and want it presented to the full Connecticut Senate. Send your letters today!

Already a Champion? Just select your prefix, type in your email, and click "send my letter."

If you are not David Jimenez, click here.

If you have participated before, just type in your email address then submit the form.

Email:*

dave@savesecond.com

First Name:*

Last Name:*

Address Line 1:*

Address Line 2:

City:*

State:*

ZIP:*

Phone Number:

* Required Field

Subject:

(Edit Letter Below)

Health decisions should be made between a patient and his or her doctor. Treatment options are both personal and medical - they should not have to be based on financial factors.

I urge you to immediately place Senate Bill 50 up for a vote before the full Senate.  Senate Bill 50 would require health insurance plans to provide coverage for oral cancer drugs on terms no less favorable than the coverage provided for intravenously-administered chemotherapy. At the same time, we must ensure that in adopting this policy, health insurers are not allowed to reduce coverage for intravenous therapies. This bill is an important first step in making sure there is no distinction between different forms of life-saving drugs in the fight against cancer and to decrease the out-of-pocket cost to Connecticut cancer patients receiving oral chemotherapy.

I hope you will stand with me in supporting this critical legislation, an important step in making sure there is no distinction between different forms of life-saving drugs in the fight against cancer in Connecticut.

Sincerely,
David Jimenez
3 Rogers Ct
Pantego, TX 76013-3167

By submitting this form, you agree to receive periodic news and action alerts from Susan G. Komen for the Cure Advocacy Alliance